NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Investments in Basic Cancer Research: Developing Crizotinib

NCI makes substantial investments in basic research, recognizing its fundamental importance in unraveling the complexities of cancer. A deeper understanding of cancer leads to new approaches for cancer prevention, screening, and treatment, like crizotinib to treat non-small cell lung cancer. Learn more about basic research in NCI's Role in Cancer Research.

Why we should invest in basic Science? It lists the development of a targeted therapy. Infographic shows the basic research steps and clinical trials to develop cancer drug crizotinib. Shows steps from 1984 when MET oncogene was discovered; 1997 when MET mutations found to be oncogenic driver mutations; 2007 when first report of a MET inhibitor and first patient treated; 2009 when Childrens’s Oncology Group (COG) opens trial for crizotinib; 2013 FDA approves crizotinib; through 2018 when FDA grants breakthr

View and Print Infographic